查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2152189

乳房超音波市場規模、佔有率和趨勢分析報告：按產品、最終用途、地區和細分市場分類（2026-2033 年）

Breast Ultrasound Market Size, Share & Trends Analysis Report By Product (Conventional Breast Ultrasound (CBUS), Automated Breast Ultrasound (ABUS)), By End Use (Hospital, Diagnostics Imaging Laboratories), By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

全球乳房超音波市場預計在 2025 年達到 26 億美元，預計從 2026 年的 30 億美元成長到 2033 年的 76 億美元，2026 年至 2033 年的複合年成長率為 14.2%。

北美市場處於領先地位，預計到 2025 年將佔全球銷售額的 35.0%。乳癌發病率上升、乳房超音波檢查需求增加、技術進步以及政府和非營利組織開展的各種宣傳活動正在推動市場成長。

根據NBC環球2024年4月發表的報導，美國預防服務工作小組（USPSTF）的專家建議，所有女性從40歲開始每年進行乳房乳房X光攝影。全球乳癌發生率的上升預計將推動對該產品的需求。癌症是全球主要死因之一，而乳癌是全球第二大常見癌症。對女性而言，乳癌是最常見的癌症。

久坐的生活方式、肥胖和飲食習慣的改變是導致乳癌的主要因素。此外，飲酒量的增加預計也會增加乳癌的風險。每天每攝取一個單位的酒精，罹患乳癌的風險就會增加約7%至10%。預計此類疾病盛行率的上升將在不久的將來導致乳房超音波檢查需求的增加。

在乳癌預防和治療需求日益成長的推動下，領先的企業和研究機構紛紛推出技術先進的產品，以鞏固其在乳房超音波市場的地位。此外，根據美國癌症協會發布的《2025年癌症事實與數據》，預計到2025年，美國女性將新增超過316,950例侵襲性乳癌病例，凸顯了對先進乳房攝影影像技術的持續需求。

此外，女性乳房組織緻密化盛行率的增加以及人們對輔助篩檢意識的提高，進一步推動了市場成長。由於乳房X乳房X光攝影對乳房組織緻密的女性往往敏感度降低，乳房超音波已成為早期發現病變的重要輔助影像技術。美國FDA的乳房密度告知規則將於2024年9月生效，該規則要求乳房X光攝影機構告知患者其乳房密度，進而提高人們對乳房超音波等輔助篩檢方式的認知。預計這一監管趨勢將在預測期內推動乳腺超音波的普及應用。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章：乳房超音波市場：變數、趨勢和範圍

  • 市場概況及未來展望
  • 市場規模和成長前景
  • 市場動態
  • 乳房超音波市場分析工具

第4章：乳房超音波市場：產品估算、趨勢分析及展望

  • 乳房超音波市場：產品特定展望及波動分析（2025 年及 2033 年）
  • 常規乳腺超音波（CBUS）
  • 自動乳房超音波（ABUS）

第5章 乳房超音波市場：依最終用途分類的估算與趨勢分析

  • 乳房超音波市場：依最終用途分類的趨勢分析，2025 年和 2033 年
  • 醫院
  • 診斷影像檢查實驗室
  • 其他

第6章 乳房超音波市場：區域估算與趨勢分析

  • 2025 年及 2033 年各地區乳房超音波市場佔有率
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • UAE
    • 科威特

第7章 競爭情勢

  • 主要市場參與企業近期趨勢及影響分析
  • 公司分類
  • 企業熱力圖分析
  • 公司簡介
    • GE HealthCare
    • Koninklijke Philips NV
    • Siemens Healthineers AG
    • CANON MEDICAL SYSTEMS CORPORATION
    • Telemed Medical Systems Srl
    • Hologic, Inc.
    • FUKUDA DENSHI
    • Supersonic Imagine
    • Lunit Inc.
    • Delphinus Medical Technologies, Inc.
簡介目錄
Product Code: GVR-3-68038-745-2

The global breast ultrasound market size was estimated at USD 2.6 billion in 2025 and is projected to grow from USD 3.0 billion in 2026 to USD 7.6 billion by 2033, growing at a CAGR of 14.2% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 35.0% in 2025. The increasing incidence of breast cancer, rise in demand for breast ultrasound, technological advancements, and various awareness initiatives undertaken by the governments and non-profit organizations are among the factors driving the market growth.

According to an article published by NBC UNIVERSAL in April 2024, experts from the U.S. Preventive Services Task Force (USPSTF) recommended that people with breasts undergo an annual mammogram starting at age 40. The rising prevalence of breast cancer across the globe is anticipated to fuel product demand. Cancer is one of the leading causes of death globally, and breast cancer is the second most common cancer worldwide. In the case of women, breast cancer tops the list of most prevalent cancers.

Rise in sedentary lifestyle, obesity, and changes in eating habits are some of the major factors contributing to breast cancer. Moreover, rising alcohol consumption is also expected to increase the risk of disease. The risk increases by around 7% to 10% per unit of alcohol consumption per day. Such an increasing prevalence of the disease is expected to boost the demand for breast ultrasound shortly.

Due to the rising demand for the prevention and treatment of this disease, key companies and research organizations are launching technologically advanced products to strengthen their foothold in the breast ultrasound market. Furthermore, the American Cancer Society's Cancer Facts & Figures 2025 estimated that more than 316,950 new invasive breast cancer cases would be diagnosed among women in the U.S. in 2025, underscoring the continued need for advanced breast imaging technologies.

In addition, the growing prevalence of dense breast tissue among women and increasing awareness regarding supplemental screening are further driving market growth. Mammography often has reduced sensitivity in women with dense breast tissue, making breast ultrasound an important complementary imaging modality for early lesion detection. According to the U.S. FDA's breast density notification rule, effective September 2024, mammography facilities are required to inform patients about breast density, increasing awareness regarding supplemental screening options such as breast ultrasound. This regulatory development is expected to support the adoption of breast ultrasound over the forecast period.

Global Breast Ultrasound Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global breast ultrasound market report based on product, end use, and region:

  • Product Outlook (Revenue, USD Billion, 2021 - 2033)

Conventional Breast Ultrasound (CBUS)

Automated Breast Ultrasound (ABUS)

  • End Use Outlook (Revenue, USD Billion, 2021 - 2033)

Hospital

Diagnostics Imaging Laboratories

Others

  • Regional Outlook (Revenue, USD Billion, 2021 - 2033)

North America

    • U.S.
    • Canada
    • Mexico

Europe

    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway

Asia Pacific

    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand

Latin America

    • Brazil
    • Argentina

Middle East and Africa (MEA)

    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Breast Ultrasound Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Breast Ultrasound Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Breast Ultrasound Market: Product Outlook Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Breast Ultrasound Market: Product Outlook Movement Analysis, USD Million, 2025 & 2033
  • 4.3. Conventional Breast Ultrasound (CBUS)
    • 4.3.1. Conventional Breast Ultrasound (CBUS) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4. Automated Breast Ultrasound (ABUS)
    • 4.4.1. Automated Breast Ultrasound (ABUS) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Breast Ultrasound Market: End-use Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Breast Ultrasound Market: End-use Movement Analysis, USD Million, 2025 & 2033
  • 5.3. Hospital
    • 5.3.1. Hospital Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4. Diagnostics Imaging Laboratories
    • 5.4.1. Diagnostics Imaging Laboratories Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Others
    • 5.5.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Breast Ultrasound Market: Regional Estimates & Trend Analysis

  • 6.1. Breast Ultrasound Market Share, By Region, 2025 & 2033, USD Million
  • 6.2. North America
    • 6.2.1. North America Breast Ultrasound Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. U.S. Breast Ultrasound Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.2.3. Canada
      • 6.2.3.1. Canada Breast Ultrasound Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.2.4. Mexico
      • 6.2.4.1. Mexico Breast Ultrasound Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe Breast Ultrasound Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.2. UK
      • 6.3.2.1. UK Breast Ultrasound Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.3. Germany
      • 6.3.3.1. Germany Breast Ultrasound Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.4. France
      • 6.3.4.1. France Breast Ultrasound Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.5. Italy
      • 6.3.5.1. Italy Breast Ultrasound Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.6. Spain
      • 6.3.6.1. Spain Breast Ultrasound Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.7. Denmark
      • 6.3.7.1. Denmark Breast Ultrasound Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.8. Sweden
      • 6.3.8.1. Sweden Breast Ultrasound Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.9. Norway
      • 6.3.9.1. Norway Breast Ultrasound Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Breast Ultrasound Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.2. Japan
      • 6.4.2.1. Japan Breast Ultrasound Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.3. China
      • 6.4.3.1. China Breast Ultrasound Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.4. India
      • 6.4.4.1. India Breast Ultrasound Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.5. Australia
      • 6.4.5.1. Australia Breast Ultrasound Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.6. South Korea
      • 6.4.6.1. South Korea Breast Ultrasound Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.7. Thailand
      • 6.4.7.1. Thailand Breast Ultrasound Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Latin America Breast Ultrasound Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Brazil Breast Ultrasound Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.3. Argentina
      • 6.5.3.1. Argentina Breast Ultrasound Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Middle East and Africa
    • 6.6.1. Middle East and Africa Breast Ultrasound Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.2. South Africa
      • 6.6.2.1. South Africa Breast Ultrasound Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.3. Saudi Arabia
      • 6.6.3.1. Saudi Arabia Breast Ultrasound Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.4. UAE
      • 6.6.4.1. UAE Breast Ultrasound Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.5. Kuwait
      • 6.6.5.1. Kuwait Breast Ultrasound Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Heat Map Analysis
  • 7.4. Company Profiles
    • 7.4.1. GE HealthCare
      • 7.4.1.1. Participant's Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Recent Developments/ Strategic Initiatives
    • 7.4.2. Koninklijke Philips N.V.
      • 7.4.2.1. Participant's Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Recent Developments/ Strategic Initiatives
    • 7.4.3. Siemens Healthineers AG
      • 7.4.3.1. Participant's Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Recent Developments/ Strategic Initiatives
    • 7.4.4. CANON MEDICAL SYSTEMS CORPORATION
      • 7.4.4.1. Participant's Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Recent Developments/ Strategic Initiatives
    • 7.4.5. Telemed Medical Systems Srl
      • 7.4.5.1. Participant's Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Recent Developments/ Strategic Initiatives
    • 7.4.6. Hologic, Inc.
      • 7.4.6.1. Participant's Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Recent Developments/ Strategic Initiatives
    • 7.4.7. FUKUDA DENSHI
      • 7.4.7.1. Participant's Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Recent Developments/ Strategic Initiatives
    • 7.4.8. Supersonic Imagine
      • 7.4.8.1. Participant's Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Recent Developments/ Strategic Initiatives
    • 7.4.9. Lunit Inc.
      • 7.4.9.1. Participant's Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Recent Developments/ Strategic Initiatives
    • 7.4.10. Delphinus Medical Technologies, Inc.
      • 7.4.10.1. Participant's Overview
      • 7.4.10.2. Financial Performance
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Recent Developments/ Strategic Initiatives